Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Cervical Cancer Clinical Practice Guidelines in Oncology JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK Koh, W., Greer, B. E., Abu-Rustum, N. R., Apte, S. M., Campos, S. M., Chan, J., Cho, K. R., Cohn, D., Crispens, M. A., DuPont, N., Eifel, P. J., Gaffney, D. K., Giuntoli, R. L., Han, E., Huh, W. K., Lurain, J. R., Martin, L., Morgan, M. A., Mutch, D., Remmenga, S. W., Reynolds, R. K., Small, W., Teng, N., Tillmanns, T., Valea, F. A., McMillian, N. R., Hughes, M. 2013; 11 (3): 320-343

Abstract

These NCCN Clinical Practice Guidelines in Oncology for Cervical Cancer focus on early-stage disease, because it occurs more frequently in the United States. After careful clinical evaluation and staging, the primary treatment of early-stage cervical cancer is either surgery or radiotherapy. These guidelines include fertility-sparing and non-fertility-sparing treatment for those with early-stage disease, which is disease confined to the uterus. A new fertility-sparing algorithm was added for select patients with stage IA and IB1 disease..

View details for Web of Science ID 000316037400011